NASDAQ:CNAT - Conatus Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$1.21 +0.01 (+0.83 %)
(As of 03/26/2019 04:00 PM ET)
Previous Close$1.20
Today's Range$1.1434 - $1.24
52-Week Range$1.14 - $6.74
Volume1.07 million shs
Average Volume878,094 shs
Market Capitalization$36.62 million
P/E Ratio-2.05
Dividend YieldN/A

Analyst Ratings

Conatus Pharmaceuticals (NASDAQ:CNAT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Conatus Pharmaceuticals in the last 12 months. Their average twelve-month price target is $5.84, suggesting that the stock has a possible upside of 382.64%. The high price target for CNAT is $12.00 and the low price target for CNAT is $1.50. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyBuy
Consensus Rating Score: 2.202.802.803.00
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.84$10.25$11.1150$12.4983
Price Target Upside: 382.64% upside404.93% upside414.58% upside213.24% upside

Conatus Pharmaceuticals (NASDAQ:CNAT) Consensus Price Target History

Price Target History for Conatus Pharmaceuticals (NASDAQ:CNAT)

Conatus Pharmaceuticals (NASDAQ:CNAT) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/26/2019Roth CapitalReiterated RatingBuy ➝ Neutral$1.70MediumView Rating Details
3/22/2019HC WainwrightDowngradeBuy ➝ Neutral$8.00 ➝ $1.50HighView Rating Details
3/22/2019SunTrust BanksDowngradeBuy ➝ HoldHighView Rating Details
12/6/2018Stifel NicolausDowngradeBuy ➝ Hold$4.00HighView Rating Details
12/6/2018OppenheimerSet Price TargetBuy$14.00 ➝ $10.00HighView Rating Details
1/24/2018S&P Equity ResearchBoost Price Target$5.02 ➝ $5.69HighView Rating Details
10/6/2017Seaport Global SecuritiesReiterated RatingBuy$16.00N/AView Rating Details
5/15/2017AegisReiterated RatingBuy$11.00N/AView Rating Details
(Data available from 3/26/2017 forward)
This page was last updated on 3/26/2019 by Staff

Featured Article: What is the Coverage Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel